Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pathogenesis of non-alcoholic fatty liver disease in children and adolescence: From “two hit theory” to “multiple hit model”
Yanlan Fang, Hong Chen, Chunlin Wang, et al.
World Journal of Gastroenterology (2018) Vol. 24, Iss. 27, pp. 2974-2983
Open Access | Times Cited: 325

Showing 1-25 of 325 citing articles:

Ferroptosis Affects the Progression of Nonalcoholic Steatohepatitis via the Modulation of Lipid Peroxidation–Mediated Cell Death in Mice
Jing Qi, Jong-Won Kim, Zixiong Zhou, et al.
American Journal Of Pathology (2019) Vol. 190, Iss. 1, pp. 68-81
Open Access | Times Cited: 261
Indole-3-Acetic Acid Alleviates Nonalcoholic Fatty Liver Disease in Mice via Attenuation of Hepatic Lipogenesis, and Oxidative and Inflammatory Stress
Yun Ji, Yuan Gao, Hong Chen, et al.
Nutrients (2019) Vol. 11, Iss. 9, pp. 2062-2062
Open Access | Times Cited: 199
Metabolic-associated fatty liver disease: a selective review of pathogenesis, diagnostic approaches, and therapeutic strategies
Mohammad Habibullah, Khaleed Jemmieh, Amr Ouda, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 32
Hyperoside attenuates non-alcoholic fatty liver disease in rats via cholesterol metabolism and bile acid metabolism
Songsong Wang, Feiya Sheng, Liang Zou, et al.
Journal of Advanced Research (2021) Vol. 34, pp. 109-122
Open Access | Times Cited: 103
Resveratrol attenuates high-fat diet-induced non-alcoholic steatohepatitis by maintaining gut barrier integrity and inhibiting gut inflammation through regulation of the endocannabinoid system
Mengting Chen, Pengfei Hou, Min Zhou, et al.
Clinical Nutrition (2019) Vol. 39, Iss. 4, pp. 1264-1275
Closed Access | Times Cited: 101
Metabolic Spectrum of Liver Failure in Type 2 Diabetes and Obesity: From NAFLD to NASH to HCC
Hyun-Mi Kim, Da Som Lee, Tae Hyeon An, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4495-4495
Open Access | Times Cited: 100
Intrauterine growth restriction: Clinical consequences on health and disease at adulthood
Jean-Baptiste Armengaud, Catherine Yzydorczyk, Bénazir Siddeek, et al.
Reproductive Toxicology (2020) Vol. 99, pp. 168-176
Open Access | Times Cited: 99
Hepatic Krüppel-like factor 16 (KLF16) targets PPARα to improve steatohepatitis and insulin resistance
Nannan Sun, Chuangpeng Shen, Lei Zhang, et al.
Gut (2020) Vol. 70, Iss. 11, pp. 2183-2195
Open Access | Times Cited: 87
MAFLD vs. NAFLD: shared features and potential changes in epidemiology, pathophysiology, diagnosis, and pharmacotherapy
Yingxin Xian, Jianping Weng, Fen Xu
Chinese Medical Journal (2020) Vol. 134, Iss. 1, pp. 8-19
Open Access | Times Cited: 86
Worldwide flavor enhancer monosodium glutamate combined with high lipid diet provokes metabolic alterations and systemic anomalies: An overview
Arnab Banerjee, Sandip Mukherjee, Bithin Kumar Maji
Toxicology Reports (2021) Vol. 8, pp. 938-961
Open Access | Times Cited: 84
Periodontal disease–related nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: An emerging concept of oral‐liver axis
Ryutaro Kuraji, Satoshi Sekino, Yvonne L. Kapila, et al.
Periodontology 2000 (2021) Vol. 87, Iss. 1, pp. 204-240
Open Access | Times Cited: 84
Childhood obesity, cardiovascular and liver health: a growing epidemic with age
Maria Felicia Faienza, Mariangela Chiarito, Emilio Molina‐Molina, et al.
World Journal of Pediatrics (2020) Vol. 16, Iss. 5, pp. 438-445
Open Access | Times Cited: 78
Role of Endocrine-Disrupting Chemicals in the Pathogenesis of Non-Alcoholic Fatty Liver Disease: A Comprehensive Review
Raquel Cano, José L. Pérez, Lissé Angarita, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4807-4807
Open Access | Times Cited: 77
Traditional Chinese Medicine in nonalcoholic fatty liver disease: molecular insights and therapeutic perspectives
Xian-min Dai, Jiayi Feng, Yi Chen, et al.
Chinese Medicine (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 62
mTOR: A Potential New Target in Nonalcoholic Fatty Liver Disease
Jiayao Feng, Shuting Qiu, Shipeng Zhou, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 9196-9196
Open Access | Times Cited: 53
Clinical Practice Guidelines of the Russian Scientific Liver Society, Russian Gastroenterological Association, Russian Association of Endocrinologists, Russian Association of Gerontologists and Geriatricians and National Society for Preventive Cardiology on Diagnosis and Treatment of Non-Alcoholic Liver Disease
В. Т. Ивашкин, M. V. Maevskaya, М. С. Жаркова, et al.
Russian Journal of Gastroenterology Hepatology Coloproctology (2022) Vol. 32, Iss. 4, pp. 104-140
Open Access | Times Cited: 48
Natural flavonoids: Potential therapeutic strategies for non-alcoholic fatty liver disease
Panli Tan, Jin Li, Xiang Qin, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 41
The National Consensus statement on the management of adult patients with non-alcoholic fatty liver disease and main comorbidities
M. V. Maevskaya, Yu. V. Kotovskaya, В. Т. Ивашкин, et al.
Terapevticheskii arkhiv (2022) Vol. 94, Iss. 2, pp. 216-253
Open Access | Times Cited: 40
The Pleiotropic Face of CREB Family Transcription Factors
Md. Arifur Rahman Chowdhury, Jungeun An, Sangyun Jeong
Molecules and Cells (2023) Vol. 46, Iss. 7, pp. 399-413
Open Access | Times Cited: 39
Arbutin alleviates fatty liver by inhibiting ferroptosis via FTO/SLC7A11 pathway
Tianyu Jiang, Yao Xiao, Jinfeng Zhou, et al.
Redox Biology (2023) Vol. 68, pp. 102963-102963
Open Access | Times Cited: 36
Association between endocrine-disrupting chemical mixtures and non-alcoholic fatty liver disease with metabolic syndrome as a mediator among adults: A population-based study in Korea
Bohyun Park, Byungmi Kim, Chung Ho Kim, et al.
Ecotoxicology and Environmental Safety (2024) Vol. 276, pp. 116310-116310
Open Access | Times Cited: 9
Targeting Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Available and Future Pharmaceutical Options
Emmanouil Koullias, Maria Papavdi, John Koskinas, et al.
Cureus (2025)
Open Access | Times Cited: 2
Effects of Plant-Based Diet on Metabolic Parameters, Liver and Kidney Steatosis: A Prospective Interventional Open-label Study
Begüm Güler Şentürk, Bengı Gürses, Ceren Soyturk, et al.
British Journal Of Nutrition (2025), pp. 1-22
Closed Access | Times Cited: 1
Peroxiredoxin 5 ameliorates obesity-induced non-alcoholic fatty liver disease through the regulation of oxidative stress and AMP-activated protein kinase signaling
Mi Hye Kim, Jung Bae Seong, Jae‐Won Huh, et al.
Redox Biology (2019) Vol. 28, pp. 101315-101315
Open Access | Times Cited: 69
Non-Alcoholic Fatty Liver Disease in Obese Youth With Insulin Resistance and Type 2 Diabetes
Serena Scapaticci, Ebe D’Adamo, Angelika Mohn, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 55
Page 1 - Next Page

Scroll to top